Literature DB >> 18385669

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice.

Chunlei Zhou1, Fengxiang Lu, Kejiang Cao, Di Xu, David Goltzman, Dengshun Miao.   

Abstract

To determine whether the cardiovascular effect of 1,25(OH)(2)D is dependent on calcium and/or phosphorus, mice with targeted deletion of the 25(OH)D 1alpha-hydroxylase and their wild-type littermates were fed a normal diet or a diet to rescue the ambient serum calcium and phosphorus levels. Mice on the normal diet were treated daily with vehicle or 1,25(OH)(2)D(3) while mice on the rescue diet received vehicle, captopril or losartan. After four weeks the vehicle-treated knockout mice developed hypertension, cardiac hypertrophy and impaired cardiac function along with an up-regulation of the renin-angiotensin system in both renal and cardiac tissues. Although the serum calcium and phosphorus levels were normalized in knockout mice on the rescue diet, abnormalities in blood pressure, cardiac structure-function and the renin-angiotensin system remained. In contrast, 1,25(OH)(2)D(3) not only normalized serum calcium and phosphorus levels but also normalized blood pressure, cardiac structure-function and the renin-angiotensin system. Treatment of the knockout mice with either captopril or losartan normalized blood pressure and cardiac structure and function although renin expression remained elevated. This study shows that 1,25(OH)2D plays a protective role in the cardiovascular system by repressing the renin-angiotensin system independent of extracellular calcium or phosphorus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385669     DOI: 10.1038/ki.2008.101

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  141 in total

Review 1.  Can vitamin D slow down the progression of chronic kidney disease?

Authors:  Rukshana Shroff; Mandy Wan; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2011-12-10       Impact factor: 3.714

Review 2.  Vitamin D: roles in renal and cardiovascular protection.

Authors:  Yan C Li
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

Review 3.  The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes.

Authors:  Anand Vaidya; Jonathan S Williams
Journal:  Metabolism       Date:  2011-11-09       Impact factor: 8.694

Review 4.  Should hypertensive patients take vitamin D?

Authors:  Gregoire Wuerzner; Michel Burnier; Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

5.  Vitamin d deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells.

Authors:  Marija Djukic; Marie Luise Onken; Sandra Schütze; Sandra Redlich; Alexander Götz; Uwe-Karsten Hanisch; Thomas Bertsch; Sandra Ribes; Andrea Hanenberg; Simon Schneider; Cornelius Bollheimer; Cornel Sieber; Roland Nau
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 6.  Vitamin D and the heart.

Authors:  David G Gardner; Songcang Chen; Denis J Glenn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-11       Impact factor: 3.619

Review 7.  Vitamin D metabolism, mechanism of action, and clinical applications.

Authors:  Daniel D Bikle
Journal:  Chem Biol       Date:  2014-02-13

8.  Common variant rs11191548 near the CYP17A1 gene is associated with hypertension and the serum 25(OH) D levels in Han Chinese.

Authors:  Ning Zhang; Jian Jia; Qiuju Ding; Huimei Chen; Xiaoman Ye; Haixia Ding; Yiyang Zhan
Journal:  J Hum Genet       Date:  2018-03-19       Impact factor: 3.172

9.  Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice.

Authors:  Q Cheng; B J Boucher; P S Leung
Journal:  Diabetologia       Date:  2012-12-19       Impact factor: 10.122

Review 10.  Vitamin D and diabetic nephropathy.

Authors:  Yan Chun Li
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.